COMPANY

COMPANY
ABOUT US
Corporate Name CURE BIOTECH Co.,Ltd.
CEO Jung-Hyeon Park
Establishment date March 30, 2017
Main product biodegradable polymers
Address 50-30, Hugi-gil, Yongdu-ri, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea
Contact Tel. +82-43-216-6700 / Fax. +82-43-216-6701
COMPANY
BUSINESS INFO
01

Biopolymers use biodegradable polymers as their raw material for medical devices in the form of fiber, fabric, powder, and injection molding.

02

Multi-filament or monofilament fibers can be used to make fiber-based products. Biodegradable fabrics can also be produced by secondary processing of these fiber forms.

03

In addition, it can be processed into powder form and used as an additive for products such as fillers for face lifting and cosmetics. The possibilities for its use are unlimited.

04

Cure Biotech biopolymers ensure excellent strength and dimensional stability when applying injection moldings. Depending on the type, decomposition time or flexibility can be different.

05

We use the principal monomers for the production of biodegradable polymers such as Glycolide, Lactide, p-Dioxanone, ε-Caprolactone, available in granule or powder form.

06

Through the ISO13485 certification, we have secured a stable production certification system, providing high-purity polymers and customized consulting services.

COMPANY
HISTORY
2022
  • Selected for a 'Promising Small and Medium-sized Enterprise Certification' by Gyeonggi provincial government in 2021
  • Participated in 2022 Arab Health
2021
  • Obtained Korea-China Certificate of Origin
  • Obtained Korea-EU Certificate of Origin
2020
  • Obtained a patent for PDCL
2019
  • Participated in 2019 Guangzhou Beauty Expo
  • Participated in 2019 Harbin Beauty Expo
2018
  • Participated in the 2018 Medical Japan Exhibition
  • Acquired Certificate of Venture Business
  • Participated in KIMES International Medical Equipment Hospital Equipment Exhibition
  • Participated in the CMEH Beijing International Medical Devices Exhibition
  • Acquired biodegradable resin production technology and obtained a patent on the biodegradable resin products.
2017
  • Participate in the CMEH Beijing International Medical Devices Exhibition
  • Acquired ISO13485 certification
  • Establishment of a subsidiary Research Institute of the company
2016
  • Established Cure Medipharm Co., Ltd.